Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2026-01-27 @ 11:24 AM
Study NCT ID:
NCT02174861
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2014-05-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-26
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-28
First Submit QC Date:
None
Study First Post Date:
2014-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-24
Results First Submit QC Date:
None
Results First Post Date:
2018-06-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-03
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL